Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Trifluridine/tipiracil (TAS-102) in refractory metastatic colorectal cancer: A multicenter register in the frame of the Italian compassionate use program
- Treosulfan, fludarabine, and low-dose total body irradiation for children and young adults with acute myeloid leukemia or myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation: Prospective phase II trial of the pediatric blood and marrow transplant consortium
- Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
- Survival outcomes for advanced kidney cancer patients in the era of targeted therapies
- Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
PHARMACOLOGY
- Clinical acceptability of trimetazidine modified-release 80 mg once daily vs trimetazidine modified-release 35 mg twice daily in stable angina pectoris
- Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia
- Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis
- Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia
- Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure
CLINICAL PHARMACOLOGY
- Abdominal skin closure using subcuticular sutures prevents incisional surgical site infection in hepatopancreatobiliary surgery
- Efficacy and safety of curcumin in treatment of intestinal adenomas in patients with familial adenomatous polyposis
- Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (SELECT)
- Pretreatment tumor thickness as a predictor of pathologic complete response to neoadjuvant chemoradiation therapy for stage II/III rectal adenocarcinoma
- Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival
ONCOLOGY
